cagrilintide semaglutide cagrisema phase 3 results 2024 2025 Novo Nosedives on Underwhelming III Weight-Loss Data Comparative Efficacy and Safety of

Refrigeration requirements Store semaglutide vials at 36 to 46 degrees Fahrenheit (2 to 8 degrees Celsius)

Clinical trials of FDA-approved semaglutide and tirzepatide show the difference clearly: Semaglutide patients lose about 15% of total body weight Tirzepatide patients lose approximately 21% Both medications can cause mild gastrointestinal side effects, but tirzepatide is often better tolerated, with many patients reporting fewer symptoms

The landmark SUSTAIN clinical trial series evaluated semaglutide in thousands of patients with type 2 diabetes, providing data on various metabolic parameters including lipid profiles

On average, patients get eight to ten pounds slimmer within the programs eight weeks if the instructions are correctly followed

Semaglutide has quickly become one of the most effective and trusted treatments for weight management and metabolic health